Cite
MLA Citation
Elaine Shum et al.. “407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A432. http://access.bl.uk/ark:/81055/vdc_100144712256.0x000001